Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Ernst Moritz Arndt University of Greifswald Fresenius AG |
---|---|
Information provided by: | Ernst Moritz Arndt University of Greifswald |
ClinicalTrials.gov Identifier: | NCT00142220 |
We study whether an increased proportion of omega-3-fatty acids (contained in fish oil) in the nutrition of critically ill patients reduces systemic inflammation.
Condition | Intervention | Phase |
---|---|---|
Sepsis Syndrome |
Drug: Defined percentage of omega-3-fatty acids |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Comparison Between Two Different Proportions of Omega-3- and Omega-6-Fatty Acids in the Parenteral Nutrition of Critically Ill Patients |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Germany | |
Internistische ITS | |
Greifswald, Germany, 17475 |
Principal Investigator: | Sigrun Friesecke, Dr. | Ernst Moritz Arndt University of Greifswald |
Study ID Numbers: | OMEGAVEN |
Study First Received: | August 31, 2005 |
Last Updated: | September 8, 2006 |
ClinicalTrials.gov Identifier: | NCT00142220 |
Health Authority: | Germany: Ethics Commission |
Systemic Inflammatory Response Syndrome Sepsis Shock Critical Illness Inflammation |
Disease Attributes Disease Pathologic Processes Syndrome |